Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard S. Lindahl currently holds 215,367 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard S. Lindahl has been a net seller of EBS stock. They have purchased $153.9K and sold $926.3K worth of shares.
Richard S. Lindahl's most recent insider trade was on Mar 5, 2026, when they sold 23,650 shares at $8.44 per share.
Richard S. Lindahl serves as Executive at Emergent BioSolutions Inc. (EBS). They have executed 101 insider transactions totaling $1.1M over their tenure at the company.
Richard S. Lindahl holds the position of Executive at Emergent BioSolutions Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Richard S. Lindahl has shown a selling trading pattern, with $153.9K in total purchases and $926.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard S. Lindahl was on Feb 6, 2026, when they sold $504.0K worth of EBS shares. This transaction involved 46,155 shares at $10.92 per share.
Richard S. Lindahl currently owns 215,367 shares of Emergent BioSolutions Inc. (EBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard S. Lindahl's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard S. Lindahl has 101 Form 4 filings on record as an insider at Emergent BioSolutions Inc..
Set alerts for Richard S. Lindahl and 40,000+ other insiders.